These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 3963982

  • 1. Erythromycin ototoxicity and acute psychotic reaction in cancer patients with hepatic dysfunction.
    Umstead GS, Neumann KH.
    Arch Intern Med; 1986 May; 146(5):897-9. PubMed ID: 3963982
    [Abstract] [Full Text] [Related]

  • 2. Clinically significant hearing loss in renal allograft recipients treated with intravenous erythromycin.
    Vasquez EM, Maddux MS, Sanchez J, Pollak R.
    Arch Intern Med; 1993 Apr 12; 153(7):879-82. PubMed ID: 8466379
    [Abstract] [Full Text] [Related]

  • 3. Erythromycin associated hearing loss in a patient with prior cis-platinum induced ototoxicity.
    Wallach PM, Love SR, Fiorica JV, Hoffman MS, Flannery MT.
    J Fla Med Assoc; 1992 Dec 12; 79(12):821-2. PubMed ID: 1474367
    [Abstract] [Full Text] [Related]

  • 4. [Ototoxic potential of erythromycin].
    Demaldent JE, Rolland A, Mongrolle Y.
    Ann Otolaryngol Chir Cervicofac; 1984 Dec 12; 101(8):643-7. PubMed ID: 6534259
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Ototoxic reaction to erythromycin.
    Agustí C, Ferrán F, Gea J, Picado C.
    Arch Intern Med; 1991 Feb 12; 151(2):380. PubMed ID: 1992966
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Erythromycin ototoxicity.
    Thompson P, Wood RP, Bergstrom L.
    J Otolaryngol; 1980 Feb 12; 9(1):60-2. PubMed ID: 7359612
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Erythromycin-induced ototoxicity.
    Méry JP, Kanfer A.
    Mayo Clin Proc; 1983 Jun 12; 58(6):401. PubMed ID: 6855278
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Hearing loss and erythromycin pharmacokinetics in a patient receiving hemodialysis.
    Kroboth PD, McNeil MA, Kreeger A, Dominguez J, Rault R.
    Arch Intern Med; 1983 Jun 12; 143(6):1263-5. PubMed ID: 6860057
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Bilateral sensorineural hearing loss from danazol therapy. A case report.
    Enyeart JJ, Price WA.
    J Reprod Med; 1984 May 12; 29(5):351-3. PubMed ID: 6726709
    [Abstract] [Full Text] [Related]

  • 17. [Experimental study of the ototoxicity of cisplatinum].
    Basterra J, Marco Algarra J, González Devesa M, Marco J, Pellin A.
    An Otorrinolaringol Ibero Am; 1985 May 12; 12(2):157-66. PubMed ID: 4039900
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Erythromycin ototoxicity in liver transplant patients.
    Moral A, Navasa M, Rimola A, García-Valdecasas JC, Grande L, Visa J, Rodés J.
    Transpl Int; 1994 May 12; 7(1):62-4. PubMed ID: 8117405
    [Abstract] [Full Text] [Related]

  • 20. Ototoxicity of high-dose cisplatin by bolus administration in patients with advanced cancers and normal hearing.
    Kopelman J, Budnick AS, Sessions RB, Kramer MB, Wong GY.
    Laryngoscope; 1988 Aug 12; 98(8 Pt 1):858-64. PubMed ID: 3398663
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.